Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2023年 / 65卷 / 1677期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Eflapegrastim-xnst (Rolvedon [Spectrum]; previously called Rolontis), a granulocyte colony-stimulating factor (G-CSF) conjugated to an Fc fragment of human IgG4, has been approved by the FDA to decrease the incidence of infection, as manifested by febrile neutropenia, in adults with nonmyeloid malignancies receiving myelosuppressive chemotherapy that can cause clinically significant febrile neutropenia.
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [1] Prevention and Treatment of Chemotherapy-Induced Febrile Neutropenia in Adults
    Park, Hye Min
    Pom, Boramey
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2023, 48 (04)
  • [2] Prevention and Treatment of Chemotherapy-Induced Febrile Neutropenia in Adults
    Park, Hye Min
    Pom, Boramey
    Farina, Kyle A.
    Rattu, Mohammad A.
    US PHARMACIST, 2023, 48 (06) : 25 - 30
  • [3] In vivo efficacy of eflapegrastim in rats with chemotherapy-induced neutropenia
    Kim, Young Hoon
    Choi, InYoung
    Kolli, Prasad
    Reddy, Guru
    CANCER RESEARCH, 2017, 77
  • [4] Chemotherapy-induced febrile neutropenia
    Temblett, Paul
    CLINICAL MEDICINE, 2008, 8 (06) : 634 - 634
  • [5] Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors
    Lambertini, Matteo
    Ferreira, Arlindo R.
    Del Mastro, Lucia
    Danesi, Romano
    Pronzato, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1799 - 1817
  • [6] Chemotherapy-induced neutropenia and febrile neutropenia during chemotherapy for gynaecologic malignancy
    Hashiguchi, Y.
    Fukuda, T.
    Ichimura, T.
    Matsumoto, Y.
    Yasui, T.
    Sumi, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S277 - S277
  • [7] Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
    Hashiguchi, Yasunori
    Kasai, Mari
    Fukuda, Takeshi
    Ichimura, Tomoyuki
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ANTI-CANCER DRUGS, 2015, 26 (10) : 1054 - 1060
  • [8] A new prognostic model for chemotherapy-induced febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Lee, Jae-Lyun
    Lim, Kyung Soo
    Yoon, Sung-Cheol
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (01) : 46 - 52
  • [9] Management of Breast Cancer Patients with Chemotherapy-Induced Neutropenia or Febrile Neutropenia
    Fontanella, Caterina
    Bolzonello, Silvia
    Lederer, Bianca
    Aprile, Giuseppe
    BREAST CARE, 2014, 9 (04) : 239 - 245
  • [10] A new prognostic model for chemotherapy-induced febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Jae-Lyun Lee
    Kyung Soo Lim
    Sung-Cheol Yoon
    International Journal of Clinical Oncology, 2016, 21 : 46 - 52
12345